封面
市場調查報告書
商品編碼
1800135

高效液相層析(HPLC)市場-2025年至2030年的預測

High Performance Liquid Chromatography (HPLC) Market - Forecasts fom 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 149 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

高效液相層析(HPLC) 市場預計將從 2025 年的 64.92 億美元成長到 2030 年的 80.9 億美元,複合年成長率為 4.50%。

全球高效液相層析(HPLC) 市場正經歷強勁成長,這得益於其在醫療保健、科研和製造業中分離和鑑定複雜混合物成分的關鍵作用。 HPLC 的高靈敏度和精確度使其成為藥物核准檢測以及執法部門檢測尿液中興奮劑等應用的首選技術。液相層析法質譜聯用 (LC-MS) 的日益普及以及生命科學研發投資的不斷增加,進一步推動了市場的發展。然而,高昂的儀器成本構成了一項重大挑戰。本摘要專為行業專業人士量身定做,概述了到 2025 年的關鍵促進因素、細分市場和競爭趨勢。

市場促進因素

HPLC 市場受到製藥、生物技術和法醫學分析領域不斷擴展的應用所驅動。該技術的精確度支持其在醫藥品認證過程中的使用,使 HPLC 成為許多國家法規遵從性的首選。 LC-MS 結合了 HPLC 的分離能力和質譜的分析能力,其日益普及也推動了市場需求。生命科學領域(尤其是在中國和印度等新興經濟體)的研發支出不斷增加,推動了 HPLC 系統的採用。製造商正專注於技術進步以提供高品質的分析解決方案,進一步推動市場成長。然而,HPLC 設備的高成本仍然是一個障礙,尤其是對於中小型企業而言,並且可能會限制市場擴張。

市場區隔分析

按產品

HPLC 市場分為儀器和耗材兩大類。儀器領域佔據了相當大的佔有率,因為它廣泛應用於各行各業的分析過程。然而,隨著色譜管柱、檢測器和其他 HPLC 耗材的技術進步,耗材領域預計將成長更快。醫療保健領域投資的增加以及 HPLC 在醫藥品認證過程中日益重要的地位,是該領域擴張的主要動力。

按地區

北美市場依然佔據主導地位,這得益於美國大量的研發投入和加拿大蓬勃發展的製藥業。該地區先進的基礎設施和對法規合規性的重視鞏固了其領先地位。同時,受中國和印度需求成長的推動,亞太地區預計將呈現最高成長率。這些國家政府和私營部門在製藥和研究領域的投資為HPLC儀器供應商創造了巨大的機會。

競爭考察

HPLC 市場的主要企業包括島津公司、安捷倫科技、菲羅門公司、賽默飛世爾科技、沃特世公司、Jasco、珀金埃爾默、諾華賽普、Bio-Rad Laboratories 和 Gilson。這些公司對持續研發的投入鞏固了其市場地位。高昂的初始投資成本和對熟練勞動力的需求構成了進入壁壘,導致現有參與者之間的市場整合。這些公司專注於產品創新和技術進步,以保持競爭力並滿足不斷變化的行業需求。

預計HPLC市場將迎來顯著成長,這主要得益於藥品核准、法醫學分析和生命科學研究等領域的關鍵應用。在技​​術進步和投資不斷成長的推動下,耗材市場和亞太地區預計將快速擴張。儘管面臨儀器成本上升的挑戰,領先企業仍透過創新和研發保持優勢。隨著對精密分析解決方案的需求不斷成長,HPLC市場預計將持續成長,尤其是在新興經濟體。

本報告的主要優點

  • 深刻分析:獲得涵蓋主要和新興地區的深入市場洞察,重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
  • 競爭格局:了解主要企業採用的策略策略,並了解正確策略的市場滲透潛力。
  • 市場趨勢和促進因素:探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議:利用洞察力來提供策略決策,在動態環境中開闢新的業務流和收益。
  • 受眾廣泛:對於新興企業、研究機構、顧問、中小企業和大型企業來說,都是有益且具有成本效益的。

它有什麼用途?

產業與市場考量、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

調查範圍

  • 2020 年至 2024 年的歷史數據和 2025 年至 2030 年的預測數據
  • 成長機會、挑戰、供應鏈前景、法律規範與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 收益成長和預測細分市場和區域分析(包括國家)
  • 公司概況(尤其是趨勢)、財務資訊和關鍵發展。

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 經營狀況

  • 市場促進因素
  • 市場限制
  • 市場機會
  • 波特五力分析
  • 產業價值鏈分析
  • 政策法規
  • 策略建議

第4章 技術展望

第5章高效液相層析(HPLC)市場(依產品)

  • 介紹
  • 裝置
  • 耗材
  • 配件

第6章高效液相層析(HPLC)市場應用

  • 介紹
  • 臨床研究
  • 診斷
  • 法醫學
  • 其他

第7章高效液相層析(HPLC)市場(按地區)

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 印度
    • 其他

第8章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第9章:公司簡介

  • Shimadzu Corporation
  • Agilent Technologies
  • Thermo Fisher Scientific
  • Waters Corporation
  • Jasco
  • PerkinElmer
  • Novasep
  • Bio-Rad Laboratories
  • Gilson
  • Danaher Corporation
  • Hitachi, Ltd.
  • Merck KGaA

第10章 附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061610974

The High Performance Liquid Chromatography (HPLC) Market is expected to grow from USD 6.492 billion in 2025 to USD 8.090 billion in 2030, at a CAGR of 4.50%.

The global High-Performance Liquid Chromatography (HPLC) market is experiencing robust growth, driven by its critical role in separating and identifying components in complex mixtures across medical, research, and manufacturing sectors. HPLC's high sensitivity and accuracy make it a preferred technology for applications such as drug approval testing and detection of performance-enhancing drugs in urine by law enforcement agencies. The market is further propelled by the growing adoption of liquid chromatography-mass spectrometry (LC-MS) and increasing investments in life sciences research and development. However, high equipment costs pose a significant challenge. This summary, tailored for industry experts, outlines key growth drivers, segmentation, and competitive trends as of 2025.

Market Growth Drivers

The HPLC market is fueled by expanding applications in pharmaceuticals, biotechnology, and forensic analysis. The technology's precision supports its use in drug approval processes, with many countries prioritizing HPLC for regulatory compliance. The rising popularity of LC-MS, which combines HPLC's separation capabilities with mass spectrometry's analytical power, enhances market demand. Increased R&D spending in life sciences, particularly in developing economies like China and India, drives adoption of HPLC systems. Manufacturers are focusing on technological advancements to deliver high-quality analytical solutions, further boosting market growth. However, the high cost of HPLC equipment remains a barrier, particularly for smaller organizations, potentially limiting market expansion.

Market Segmentation Analysis

By Product

The HPLC market is segmented into instruments and consumables. The instrument segment holds a significant share due to widespread use in analytical processes across industries. However, the consumables segment is expected to grow at a faster rate, driven by technological advancements in columns, detectors, and other HPLC consumables. Growing healthcare investments and the increasing importance of HPLC in drug approval processes significantly contribute to this segment's expansion.

By Geography

North America remains a dominant market, driven by extensive R&D investments in the United States and a thriving pharmaceutical industry in Canada. The region's advanced infrastructure and focus on regulatory compliance support its leadership. The Asia-Pacific region, however, is projected to experience the highest growth rate, fueled by rising demand from China and India. Government and private sector investments in pharmaceuticals and research in these countries create substantial opportunities for HPLC equipment vendors.

Competitive Insights

Key players, including Shimadzu Corporation, Agilent Technologies, Phenomenex, Thermo Fisher Scientific, Waters Corporation, Jasco, PerkinElmer, Novasep, Bio-Rad Laboratories, and Gilson, dominate the HPLC market. Their ability to invest in continuous R&D strengthens their market positions. High initial investment costs and the need for skilled labor create barriers to entry, consolidating the market among established players. These companies focus on product innovation and technological advancements to maintain competitiveness and meet evolving industry needs.

The HPLC market is poised for significant growth, driven by its critical applications in drug approval, forensic analysis, and life sciences research. The consumables segment and Asia-Pacific region are expected to see rapid expansion, supported by technological advancements and increasing investments. Despite challenges from high equipment costs, major players maintain dominance through innovation and R&D. As demand for precise analytical solutions grows, the HPLC market is set to thrive, particularly in emerging economies.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2020 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

The High-Performance Liquid Chromatography market has been segmented by product, application, and geography.

By Product

  • Instruments
  • Consumables
  • Accessories

By Application

  • Clinical Research
  • Diagnostic
  • Forensic
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • Others
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • Japan
  • China
  • South Korea
  • India
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) MARKET BY PRODUCT

  • 5.1. Introduction
  • 5.2. Instruments
  • 5.3. Consumables
  • 5.4. Accessories

6. HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Clinical Research
  • 6.3. Diagnostic
  • 6.4. Forensic
  • 6.5. Others

7. HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. United States
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. United Kingdom
    • 7.4.4. Others
  • 7.5. Middle East & Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. UAE
    • 7.5.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. China
    • 7.6.2. Japan
    • 7.6.3. South Korea
    • 7.6.4. India
    • 7.6.5. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Shimadzu Corporation
  • 9.2. Agilent Technologies
  • 9.3. Thermo Fisher Scientific
  • 9.4. Waters Corporation
  • 9.5. Jasco
  • 9.6. PerkinElmer
  • 9.7. Novasep
  • 9.8. Bio-Rad Laboratories
  • 9.9. Gilson
  • 9.10. Danaher Corporation
  • 9.11. Hitachi, Ltd.
  • 9.12. Merck KGaA

10. APPENDIX

  • 10.1. Currency
  • 10.2. Assumptions
  • 10.3. Base and Forecast Years Timeline
  • 10.4. Key Benefits for the Stakeholders
  • 10.5. Research Methodology
  • 10.6. Abbreviations